Translate Bio, Inc.
Translate Bio, Inc., a pioneering biotechnology firm based in the United States, focuses on the development of mRNA therapeutics. Founded in 2016, the company has rapidly advanced its position within the biopharmaceutical industry, particularly in the areas of genetic medicine and vaccine development.
With its headquarters in Lexington, Massachusetts, Translate Bio has made significant strides in harnessing the potential of messenger RNA to create innovative treatments for various diseases. The company's core offerings include mRNA-based therapeutics designed to address unmet medical needs, setting it apart through its unique approach to drug development.
Recognised for its contributions to the field, Translate Bio has established itself as a key player in the biotechnology landscape, particularly in the context of rapid advancements in mRNA technology.
+62 vs industry average
Translate Bio, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Translate Bio, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Translate Bio, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Translate Bio, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Translate Bio, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project